Arrowhead Pharmaceuticals
ARWR
#2190
Rank
S$11.36 B
Marketcap
S$81.17
Share price
-2.07%
Change (1 day)
399.88%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2025 (TTM): S$0.46 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are S$1.09 Billion. , an increase over its 2024 earnings that were of -S$0.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 S$0.43 B-157.5%
2024 -S$0.77 Billion112.45%
2023 -S$0.36 Billion87.79%
2022 -S$0.2 Billion-20.1%
2021 -S$0.24 Billion67.59%
2020 -S$0.15 Billion-347.53%
2019 S$57.76 M-245.59%
2018 -S$39.68 Million-13.17%
2017 -S$45.7 Million-52.28%
2016 -S$95.76 Million-16.57%
2015 -S$0.12 Billion30.32%
2014 -S$88.08 Million171.62%
2013 -S$32.43 Million16.56%
2012 -S$27.82 Million107.53%
2011 -S$13.41 Million
2008 -S$47.22 Million-8.07%
2007 -S$51.36 Million70.37%
2006 -S$30.15 Million122.51%
2005 -S$13.55 Million147.41%
2004 -S$5.48 Million2002.28%
2003 -S$0.27 Million-85.61%
2002 -S$1.82 Million1371.97%
2001 -S$0.13 Million-13.45%
2000 -S$0.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$42.69 B 9,621.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-S$3.51 Billion-899.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$0.20 B-52.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.15 Billion-134.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$0.73 B 66.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-S$0.14 Billion-131.32%๐Ÿ‡บ๐Ÿ‡ธ USA